"/> Novus Biologicals™ Peptide bloquant d’anticorps DR… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps DRAM

Réf. : BL-RE-045046Réf. fabricant : 18290626 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
55332
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76759. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acid peptide from near the amino terminus of human DRAM.

Points forts

Source

Synthetic

(Accession #: AAH18435) The DRAM Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-045046
Réf. fabricant18290626
Gene ID (Entrez)55332
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76759. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneDamage-regulated autophagy modulator, DNA damage-regulated autophagy modulator protein 1, DNA-damage regulated autophagy modulator 1, DRAMFLJ11259
Symbole de gène(s)DRAM1
Type de produitDRAM
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acid peptide from near the amino terminus of human DRAM
Une question, une configuration particulière ?
Contactez-nous pour un devis.